Literature DB >> 11777979

Progression of armed CTL from draining lymph node to spleen shortly after localized infection with herpes simplex virus 1.

Richard M Coles1, Scott N Mueller, William R Heath, Francis R Carbone, Andrew G Brooks.   

Abstract

We have examined the generation of CTL immunity immediately after localized footpad infection with herpes simplex virus 1 (HSV-1) using three coordinated in vivo T cell tracking methodologies. Tetrameric MHC class I containing the immunodominant peptide from HSV-1 glycoprotein B (gB) showed that after infection the proportion of Ag-specific T cells peaked at day 5 within draining popliteal lymph nodes and 2 days later in the spleen. Preferential expression of the activation marker CD25 by tetramer-positive cells in draining popliteal nodes but not spleen suggested that gB-specific T cells were initially activated within the lymph node. In vivo cytotoxicity assays showed that Ag-specific effector cells were present within the draining lymph nodes as early as day 2 after infection, with a further 2-day lag before detection in the spleen. Consistent with the very early arming of effector CTL in the draining lymph node, adoptive transfer of CFSE-labeled gB-specific transgenic T cells showed that they had undergone one to four rounds of cell division by day 2 after infection. In contrast, proliferating T cells were first detected in appreciable numbers in the spleen on day 4, at which time they had undergone extensive cell division. These data demonstrate that HSV-1-specific T cells are rapidly activated and armed within draining lymph nodes shortly after localized HSV-1 infection. This is followed by their dissemination to other compartments such as the spleen, where they further proliferate in an Ag-independent fashion.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11777979     DOI: 10.4049/jimmunol.168.2.834

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  79 in total

1.  Leishmania-infected macrophages are targets of NK cell-derived cytokines but not of NK cell cytotoxicity.

Authors:  Chittappen K Prajeeth; Simone Haeberlein; Heidi Sebald; Ulrike Schleicher; Christian Bogdan
Journal:  Infect Immun       Date:  2011-04-25       Impact factor: 3.441

2.  Detailed analysis of the CD8+ T-cell response following adenovirus vaccination.

Authors:  Teng Chih Yang; Kelley Dayball; Yong Hong Wan; Jonathan Bramson
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

3.  Shutdown of an acute T cell immune response to viral infection is mediated by the proapoptotic Bcl-2 homology 3-only protein Bim.

Authors:  Marc Pellegrini; Gabrielle Belz; Philippe Bouillet; Andreas Strasser
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-17       Impact factor: 11.205

4.  Kinetics of virus-specific CD8+ -T-cell expansion and trafficking following central nervous system infection.

Authors:  Norman W Marten; Stephen A Stohlman; Jiehao Zhou; Cornelia C Bergmann
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

5.  Vaginal protection and immunity after oral immunization of mice with a novel vaccine strain of Listeria monocytogenes expressing human immunodeficiency virus type 1 gag.

Authors:  Xinyan Zhao; Manxin Zhang; Zhongxia Li; Fred R Frankel
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

6.  Reevaluating the CD8 T-cell response to herpes simplex virus type 1: involvement of CD8 T cells reactive to subdominant epitopes.

Authors:  Brian S Sheridan; Thomas L Cherpes; Julie Urban; Pawel Kalinski; Robert L Hendricks
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

7.  Memory CD8+ T cells are gatekeepers of the lymph node draining the site of viral infection.

Authors:  Ren-Huan Xu; Min Fang; Andres Klein-Szanto; Luis J Sigal
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-19       Impact factor: 11.205

8.  Bioluminescence imaging reveals systemic dissemination of herpes simplex virus type 1 in the absence of interferon receptors.

Authors:  Gary D Luker; Julie L Prior; Jiling Song; Christina M Pica; David A Leib
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

9.  Estimating in vivo death rates of targets due to CD8 T-cell-mediated killing.

Authors:  Vitaly V Ganusov; Rob J De Boer
Journal:  J Virol       Date:  2008-09-24       Impact factor: 5.103

10.  Terminal deoxynucleotidyl transferase establishes and broadens antiviral CD8+ T cell immunodominance hierarchies.

Authors:  S M Mansour Haeryfar; Heather D Hickman; Kari R Irvine; David C Tscharke; Jack R Bennink; Jonathan W Yewdell
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.